The Staging System of Metastatic Lymph Node Ratio in Gastric Cancer

Clinical Oncology

Volumn 19, Issue 4, 2007, Pages 269-270

  Yu, J X ^a   Li, Y ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME;

CHINA; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 34047267503     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.02.003     Document Type: Letter

References (4)

1. Kunisaki C., Shimada H., Nomura M., et al. Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res 25 (2005) 1369-1375
2. Hyung W.J., Noh S.H., Yoo C.H., et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 26 (2002) 323-329
3. Inoue K., Nakane Y., Iiyama H., et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9 (2002) 27-34
4. Rodriguez Santiago J.M., Munoz E., Marti M., Quintana S., Veloso E., and Marco C. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol 31 (2005) 59-66